A fixed-dose 24-hour regimen of artesunate plus sulfamethoxypyrazine-pyrimethamine for the treatment of uncomplicated Plasmodium falciparum malaria in eastern Sudan

BACKGROUND: Artemisinin-based combination therapy is increasingly being adopted as first-line antimalarial therapy. The choice of appropriate therapy depends on efficacy, cost, side effects, and simplicity of administration. METHODS: the efficacy of fixed co-formulated (f) artesunate-sulfamethoxypyr...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Adam, Ishag, Magzoub, Mamoun, Osman, Maha E, Khalil, Insaf F, Alifrangis, Michael, Elmardi, Khalid A
Format: Artigo
Langue:Inglês
Publié: BioMed Central 2006
Sujets:
Research
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1560156/
https://ncbi.nlm.nih.gov/pubmed/16934158
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1476-0711-5-18
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires